N/A N=254 Media, Morphokinetics, and Mosaicism
Embryonic Mosaicism · Embryo Culture Media · Embryo Morphokinetics
Primary: Aneuploidy Rates — 56.1; 62.3 percentage of embryos — p=0.07
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=88 Embryo Culture Under Constant 5% vs Gradient 8%, 5%, 2% Oxygen Concentration
Embryonic Development · Embryo Morphokinetics · Embryo Morphometry
Primary: Proportion of Inseminated Oocytes Developed to the Morphologically Optimal Blastocysts on Day 5 — 27; 38 Oocytes
N/A N=300 Use of Time-lapse Morphological Kinetics in the Selection of Blastocysts
Viability
Primary: Clinical Pregnancy Rate — 73; 81 Participants — p=0.41
N/A N=220 PGT-A Versus Blastocyst Morphology Selection
Pregnancy
Primary: The Percentage of Patients With a Live Birth — 45; 65 Participants
N/A N=661 Single Embryo TrAnsfeR of Euploid Embryo
Infertility · Aneuploidy
Primary: Ongoing Pregnancy — 137; 143 Participants
Phase 4 N=15 Effect of hCG on Receptivity of the Human Endometrium
Infertility · Subfertility
Primary: Endometrial Staging in hCG Versus Vehicle Treated Patients — 4.0; 4.6; 3.9; 6.5 days — p=<0.05
N/A N=335 Embryo Transfer With Self-spent Culture Medium
in Vitro Fertilization
Primary: Number of Participants Pregnant After 4 Weeks — 85; 82 Participants
N/A N=108 A Sibling Oocyte Study- Comparison of ZyMotTM Microfluidics Device to Density Gradient for Sperm Selection During ICSI
ART
Primary: Percentage of Good Quality Blastocyst Formation — 51.4; 51.7 percentage of embryos
Phase 4 N=970 TiLE (Time Lapse Eeva) Clinical Trial
Fertility
Primary: Implantation Rate — 30.1; 35.3 % of sacs per embryo transferred
N/A N=62 Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator
Fertility
Primary: Number of Participants With a Positive bHCG Level as Detected by a Blood Test — 19; 19 Participants
Phase 3 N=1,390 Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)
Infertility
Primary: Percentage of Participants With ≥1 Vital Pregnancy (Cumulative Vital Pregnancy Rate) — 31.1; 33.0 Percentage of Participants